Mouse Models of Novel Sphingolipid Biology and Disease Mechanisms
$322,101Z01FY2008DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Abstract
The sphingolipid metabolic pathway yields highly active lipid signaling molecules that regulate many physiologic processes during development and for homeostasis in the adult. Furthermore, the pathway is highly regulated and appears to function abnormally in certain disordered states such as in cancer and in metabolic diseases. We are utilizing genetically altered mice that are modified in their sphingolipid metabolism and signaling to uncover new functions of sphingolipids in normal biology and in disease.
View original record on NIH RePORTER →